Montreux Equity Partners
   
 

Latest News

January 3, 2008
Montreux Equity Partners Closes $250 Million MEP IV Life Sciences Fund

November 7, 2007
ARYx Therapeutics, Inc. Announces Pricing of its Initial Public Offering

September 24, 2007
Verus Pharmaceuticals Announces Divestiture of Pediatric Asthma Development Programs to AstraZeneca

September 4, 2007
NeurogesX Announces Positive Results from Second Phase 3 Clinical



Action. Experience. Collaboration.

Montreux Equity Partners is a life sciences venture capital firm focused on building great pharmaceutical and medical device companies. Montreux's goal is to generate significant returns by investing in superior businesses with high quality management teams.

Montreux seeks investment opportunities in which it can add value beyond the commitment of capital. Montreux works with entrepreneurs and management teams who wish to operate in a dynamic partnership based on shared interests and common goals. Montreux's operating philosophy is anchored in a foundation of honesty, integrity, and uncompromising professionalism.

©2008 Montreux Equity Partners. All Rights Reserved.